ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,682,000 | +87.2% | 170,000 | +142.9% | 1.03% | +24.0% |
| Q2 2022 | $1,967,000 | -79.5% | 70,000 | -66.3% | 0.83% | -45.9% |
| Q1 2022 | $9,574,000 | -3.1% | 207,500 | +76.6% | 1.53% | -57.3% |
| Q4 2021 | $9,877,000 | +91.2% | 117,500 | +51.6% | 3.59% | +175.1% |
| Q3 2021 | $5,165,000 | -31.8% | 77,500 | -45.6% | 1.30% | -51.9% |
| Q2 2021 | $7,577,000 | +125.3% | 142,418 | +83.8% | 2.71% | +137.6% |
| Q1 2021 | $3,363,000 | – | 77,500 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |